Acute Gallbladder Disease: Rarely, GLP-1 meds can cause issues with the gallbladder leading to symptoms like nausea, vomiting, bloating and abdominal pain
Administration of GSH precursors like cysteine/N-acetylcysteine, glycine and/or glutamic acid will facilitate the synthesis of GSH within each cell of the body including the atherosclerotic plaque, reducing ROS and LDL oxidation, enhancing NO production, and mitigating atherosclerosis and its complications (221229)
It is not a drug, food, or cosmetic , and has not been approved by the FDA to diagnose, treat, or cure any condition
The intrinsic pathway (mitochondrial pathway) is triggered by DNA damage, oxidative stress, and other factors
in a rodent ischemia-reperfusion model, who reported a reduced expression of CD11b in rats receiving GLP-1 therapy [63]